Skip to content
POM-V Prescription Required Companion Animal

Spizobactin 3,000,000 IU / 500 mg Chewable Tablets for Dogs

Active ingredients: Metronidazole, Spiramycin

Form

Chewable

Species

Dogs

Manufacturer

Le Vet Beheer B.V.

VMD MA No.

41821/4049

What it's used for

gingivitis, glossitis, periodontitis, tonsillitis, dental fistula and other fistulous wounds in the oral cavity, cheilitis and sinusitis – in dogs caused b...

Full indications, dosage and side effects ↓
View official SPC (PDF)

The prescription itself has a price. See what practices near you charge for a consultation and the written prescription fee.

Paying less for Metronidazole + Spiramycin

  1. 1

    Ask your vet for a written prescription

    They must provide one on request. Under the CMA Order the fee is capped at £21 from 2027.

  2. 2

    Fill it at a registered online retailer

    The CMA found online pharmacies 50–60% cheaper than practice dispensing on common medicines — typically £200–£300 a year.

Prescription required

Your vet must provide a written prescription on request. You can then purchase from any licensed online retailer.

Clinical information

Spizobactin 3,000,000 IU / 500 mg Chewable Tablets for Dogs — SPC Details

Source: VMD Summary of Product Characteristics (SPC). Last updated 27 Mar 2026.

gingivitis, glossitis, periodontitis, tonsillitis, dental fistula and other fistulous wounds in the
oral cavity, cheilitis and sinusitis – in dogs caused by microorganisms susceptible to
AN: 00121/2025 & 001235/2025
spiramycin / metronidazole, such as Gram-positive bacteria and anaerobes (see also
section 3.4 and 3.5).
AN: 00121/2025 & 001235/2025
75 000 IU spiramycin + 12.5 mg metronidazole per kg body weight, in more severe cases
100 000 IU spiramycin + 16.7 mg metronidazole per kg body weight, administered daily for
6 - 10 days depending on the severity of the disease.
In severe cases one can start with the higher dose and go back in the course of treatment
on to the lower dose.
The daily dose may be given once daily or divided equally for twice daily administration.
The treatment should always be continued for 1-2 days after resolution of symptoms in
order to prevent relapses. The tablets are to be administered either deep in the mouth (on
the base of the tongue) or given with a small amount of food containing the tablet, to ensure
all the tablet is consumed.
To ensure a correct dosage, body weight should be determined as accurately as possible.
The following table is intended as a guide to dispensing the veterinary medicinal product at
approximately the standard dose rate of 75 000 IU spiramycin + 12.5 mg metronidazole per
kg body weight.
Body weight
Spizobactin
750,000 IU / 125 mg
for dogs
Spizobactin
1,500,000 IU / 250 mg
for dogs
Spizobactin
3,000,000 IU / 500 mg
for dogs
2.5 kg 5.0 kg 7.5 kg 10 kg12.5 kg 15 kg17.5 kg 20 kg 25 kg 30 kg 35 kg 40 kg 50 kg 60 kg 70 kg 80 kg
= ¼ Tablet = ½ Tablet = ¾ Tablet = 1 Tablet
AN: 00121/2025 & 001235/2025
Tablets can be divided into 2 or 4 equal parts to ensure accurate dosing. Place the tablet on
a flat surface, with its scored side facing up and the convex (rounded) side facing the
surface.
Halves: press down with your thumbs on both
sides of the tablet.
Quarters: press down with your thumb in the
middle of the tablet
Do not use in cases of hepatic disorders.
Do not use in cases of hypersensitivity to the active substances or to any of the excipients.
Dogs:
Rare
(1 to 10 animals / 10 000 animals treated):
Vomiting
Hypersensitivity
a
Very rare
(<1 animal / 10 000 animals treated,
including isolated reports):
Haematuria
Male reproductive tract disorder
b
a
In cases of hypersensitivity reactions, treatment should be stopped.
b
Spermatogenesis disorder
Reporting adverse events is important. It allows continuous safety monitoring of a veterinary
medicinal product. Reports should be sent, preferably via a veterinarian, to either the
marketing authorisation holder or its local representative or the national competent authority
via the national reporting system. See the package leaflet for respective contact details.
In many cases of endodontic/periodontal disease the primary treatment is non-medicinal
and does not require antimicrobial medication.
Antimicrobial treatment of periodontal disease should be accompanied or preceded by
endodontic therapy and/or professional dental cleaning especially if the disease is
advanced. Dog owners are encouraged to routinely brush their dog's teeth to remove
plaque to prevent or to control periodontal disease.

Special precautions for safe use in the target species:
The combination of spiramycin and metronidazole should not be used as first-line empirical
treatment.
Whenever possible, metronidazole and spiramycin should only be used based on
susceptibility testing of the pathogens.
Use of the product should be in accordance with official, national and regional antimicrobial
policies.
Limiting the duration of treatment is necessary because damage to the germ cells cannot be
excluded with the use of metronidazole, and because in long-term studies with high doses,
an increase of certain tumours was seen in rodents. The chewable tablets are flavoured. In
order to avoid any accidental ingestion, store tablets out of reach of the animals.
Special precautions to be taken by the person administering the veterinary medicinal
product to animals:
Metronidazole has confirmed mutagenic and genotoxic properties in laboratory animals as
well as in humans. Metronidazole is a confirmed carcinogen in laboratory animals and has
possible carcinogenic effects in humans. However, there is inadequate evidence in humans
for the carcinogenicity of metronidazole.
Metronidazole may be harmful for the unborn child. Pregnant women should be careful
when handling this veterinary medicinal product.
Spiramycin and metronidazole may in rare cases induce hypersensitivity reactions, e.g.
contact dermatitis.
Direct contact with the skin or mucous membranes of the user should be avoided because
of the risk of sensitization. People with known hypersensitivity to the active substances or to
any of the excipients should avoid contact with the veterinary medicinal product.
Personal protective equipment consisting of impervious gloves should be worn when
handling the veterinary medicinal product to avoid skin contact and hand-to-mouth contact
with the veterinary medicinal product.
Metronidazole may cause adverse (neurological) effects if ingested by a child. To avoid
accidental ingestion, particularly by a child, unused part-tablets should be returned to the
open blister space and inserted back into the carton.
AN: 00121/2025 & 001235/2025
In case of accidental ingestion, seek medical advice immediately and show the package
leaflet or the label to the physician.
Wash hands thoroughly after handling the tablets.
Special precautions for the protection of the environment:
Not applicable.
Do not use concomitantly with bactericidal antibiotics.
Macrolides, such as e.g. spiramycin act antagonistic to penicillins and cephalosporins.
The veterinary medicinal product should not be used concurrently with other antibiotics of
the macrolide group.
Metronidazole may have an inhibitory effect on the degradation of other drugs in the liver,
such as phenytoin, cyclosporine and warfarin.
Phenobarbital may increase hepatic metabolism of metronidazole resulting in decreased
serum concentration of metronidazole.
Do not store above 30 °C.
Not applicable.

This information is sourced from the official Summary of Product Characteristics (SPC) published by the Veterinary Medicines Directorate (VMD). It is provided for informational purposes only and does not replace professional veterinary advice. Always consult your vet before administering any medication.

Medication costs adding up?

Pet insurance can cover prescription medications. Find the right policy for your pet.

Compare insurance

Find cheaper vets near you

Compare vet consultation prices in your area. Save on procedures and get a prescription to buy medications online.